CINECA IRIS Institutional Research Information System

BUTNARASU, Cosmin Stefan
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.434
AS - Asia 1.636
EU - Europa 1.576
SA - Sud America 201
AF - Africa 35
OC - Oceania 5
Totale 5.887
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.365
SG - Singapore 739
IT - Italia 698
CN - Cina 335
VN - Vietnam 174
IE - Irlanda 160
BR - Brasile 154
DK - Danimarca 127
SE - Svezia 117
DE - Germania 94
FR - Francia 78
BD - Bangladesh 75
FI - Finlandia 75
JP - Giappone 54
HK - Hong Kong 50
IN - India 49
GB - Regno Unito 44
ID - Indonesia 44
CA - Canada 40
KR - Corea 39
NL - Olanda 35
BE - Belgio 23
UA - Ucraina 22
IQ - Iraq 19
AR - Argentina 18
PT - Portogallo 18
ES - Italia 16
PL - Polonia 16
AT - Austria 14
MX - Messico 12
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EC - Ecuador 6
EE - Estonia 6
JM - Giamaica 6
KE - Kenya 6
TN - Tunisia 6
ZA - Sudafrica 6
AU - Australia 5
IR - Iran 5
JO - Giordania 5
PK - Pakistan 5
RU - Federazione Russa 5
CH - Svizzera 4
CO - Colombia 4
NP - Nepal 4
PY - Paraguay 4
RO - Romania 4
TR - Turchia 4
VE - Venezuela 4
AZ - Azerbaigian 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GR - Grecia 3
MA - Marocco 3
TW - Taiwan 3
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GY - Guiana 2
HR - Croazia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NO - Norvegia 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
SI - Slovenia 2
TH - Thailandia 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GE - Georgia 1
HN - Honduras 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
MD - Moldavia 1
MG - Madagascar 1
MU - Mauritius 1
MY - Malesia 1
NA - Namibia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TC - Turks e Caicos 1
UY - Uruguay 1
Totale 5.887
Salva come PNG Salva come JPEG
Città #
Singapore 424
Ashburn 251
Santa Clara 240
Chandler 230
Ann Arbor 215
Turin 209
San Jose 193
Dublin 158
Beijing 106
Milan 68
Nyköping 63
Ho Chi Minh City 56
Fairfield 50
Torino 49
Lauterbourg 45
Tokyo 45
The Dalles 43
Dallas 42
Los Angeles 42
Munich 38
Seoul 38
Jakarta 37
Rome 36
Columbus 33
Hefei 33
Helsinki 33
Hong Kong 33
New York 33
Princeton 32
Buffalo 31
Wilmington 29
Hanoi 27
Houston 25
Jacksonville 25
Medford 24
Boston 23
Dong Ket 23
Turku 20
Florence 18
Frankfurt am Main 18
Lappeenranta 18
São Paulo 17
Redondo Beach 15
Bengaluru 14
Cambridge 14
Council Bluffs 14
Dearborn 14
Guangzhou 14
Hebei 14
Basingstoke 13
Hangzhou 13
Orem 13
Boardman 12
Toronto 12
Woodbridge 12
Amsterdam 11
Palermo 11
Redwood City 11
Shanghai 11
Stockholm 11
Brooklyn 10
Chicago 10
Malmo 10
Montreal 10
Brussels 9
Fremont 9
Seattle 9
Vienna 9
Baghdad 8
Bologna 8
Chennai 8
Da Nang 8
San Diego 8
Bari 7
Genoa 7
Atlanta 6
Berlin 6
Bornem 6
Falkenstein 6
Gorgonzola 6
Memphis 6
Paris 6
Rio de Janeiro 6
Washington 6
Hyderabad 5
Krakow 5
Madrid 5
Maia 5
Manchester 5
Mexico City 5
Nairobi 5
Padua 5
Verona 5
Amman 4
Cagliari 4
Catania 4
Delhi 4
Dubai 4
Fortaleza 4
Guarulhos 4
Totale 3.659
Salva come PNG Salva come JPEG
Nome #
A biosimilar mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies 314
Squaraine Dyes: Interaction with Bovine Serum Albumin to Investigate Supramolecular Adducts with Aggregation-Induced Emission (AIE) Properties 291
Drugs and mucus: understanding the way of interaction 266
A PI3Kγ mimetic peptide triggers CFTR gating, bronchodilation, and reduced inflammation in obstructive airway diseases 252
Interaction of squaraine dyes with proteins: Looking for more efficient fluorescent turn-on probes 176
Mucin binding to therapeutic molecules: The case of antimicrobial agents used in cystic fibrosis 170
Carbon nanodots as nanocarrier for delivery of Squaraines: an in vitro evaluation to investigate their Photodynamic activity 168
A mucus model to evaluate the diffusion of drugs for more efficient cystic fibrosis therapies 144
Carbon nanodots as nanocarrier for Squaraines: an in vitro evaluation of their Photodynamic activity 142
Carbon nanodots as delivery system for Squaraines: an in vitro study to investigate their Photodynamic activity 137
Drugs and mucus: an innovative biosimilar mucus model to study the diffusion of drugs 134
Emissive PLGA and HSA Nanoparticles loaded with Polymethine dyes 130
Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies 129
Drugs and mucus: an innovative mucus model to investigate the diffusion of drugs 128
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kγ for therapeutic cAMP modulation in pulmonary cells 122
Unveiling the interaction between PDT active squaraines with ctDNA: A spectroscopic study 117
Detection of mucin glycoproteins: looking for selective turn-on fluorescent probes 113
Unlocking the AhR Therapeutic Potential for Cystic Fibrosis With an Integrated Mucosal Platform for Drug Screening 112
A turn-on fluorescent probe for mucin glycoproteins detection 112
Mucosomes: Intrinsically Mucoadhesive Glycosylated Mucin Nanoparticles as Multi-Drug Delivery Platform 111
“Occhio” alle nanotecnologie nella terapia oftalmica 109
Squaraine dyes as fluorescent turn-on probes for the detection of mucin 107
Squaraine Dyes as Fluorescent Turn-on Probes for Mucins: A Step Toward Selectivity 105
Squaraine dyes as fluorescent turn-on probes for the detection of proteins 105
Disassembling the complexity of mucus barriers to develop a fast screening tool for early drug discovery 104
Squaraine dyes as fluorescent turn-on sensors for the detection of porcine gastric mucin: A spectroscopic and kinetic study 104
Looking for turn-on fluorescent probes for mucin glycoprotein detection 104
Molecular insight into drugs binding to ctDNA: the fluorescence fast kinetic analysis of diclofenac and pentamidine 104
Mucosomes: a novel multi drug delivery platform bioinspired from mucin immunomodulatory and antimicrobial activity 102
Drugs and mucus: an innovative model to investigate the diffusion of drugs 101
Front cover: "Cystic Fibrosis Mucus Model to Design More Efficient Drug Therapies" (Molecular Pharmaceutics 02/2022) 97
Mucus model to study the diffusion of drugs through mucosal surfaces 95
Squaraine Dyes as selective probes for mucin detection 93
UNTIE THE SKEIN: DECIPHERING THE MECHANISMS GOVERNING THE INTERACTION OF DRUGS WITH MUCUS USING A BIOSIMILAR MUCUS MODEL 93
Drugs and mucus: Deciphering the interaction mechanisms using a biosimilar mucus model 93
Permeability Assessment of a High-Throughput Mucosal Platform 92
PERMEABILITY OF QUORUM SENSING SIGNAL MOLECULES THROUGH A MUCUS MODEL: AN LC-MS/MS QUANTITATIVE ANALYSIS 91
Mucosomes as next-generation drug carriers for treating mucus-resident bacterial infections and biofilms 90
Mucosomes: intrinsically glycosylated mucin nanoparticles as drug delivery platform 87
. Fluorescent Probes for Mucins: Polymethine Dyes in early Cancer Detection 81
DETERMINATION OF DRUGS PERMEABILITY ON MUCUS MODELS BY HPLC-MS 81
Tracing the path of Quorum sensing molecules in cystic fibrosis mucus in a biomimetic in vitro permeability platform 79
Understanding the mechanisms governing the interaction of drugs with mucus using a novel biosimilar mucus model 78
Exploring the formation of Advanced Glycation End Products (AGE) in different reaction conditions 75
Squaraine dyes: fluorescence turn-on for protein detection and quantification 73
Synthetic Mucin Gels with Self-Healing Properties Augment Lubricity and Inhibit HIV-1 and HSV-2 Transmission 68
Understanding the mechanisms governing the interaction of drugs with mucus using a novel biosimilar mucus model 65
Heterogeneity Governs 3D‐Cultures of Clinically Relevant Microbial Communities 64
Interplay between biofilm microenvironment and pathogenicity of Pseudomonas aeruginosa in cystic fibrosis lung chronic infection 60
Thiolated polyglycerol sulfate as potential mucolytic for muco-obstructive lung diseases 57
Commercially Available Cell-Free Permeability Tests for Industrial Drug Development: Increased Sustainability through Reduction of In Vivo Studies 47
Structural determinants of mucins in influenza virus inhibition: The role of sialylated glycans and molecular size 30
Unlocking the AhR Therapeutic Potential for Cystic Fibrosis with an Integrated Mucosal platform for Drug Screening 11
Biophysical and aerodynamic properties of a peptide targeting the A-kinase anchoring function of PI3Kγ for pulmonary cAMP modulation 7
Unlocking the AhR Therapeutic Potential for Cystic Fibrosis with an Integrated Mucosal Platform for Drug Screening 7
A nonnatural peptide targeting the A-kinase anchoring function of PI3Kg for therapeutic cAMP modulation in pulmonary cells 4
Totale 6.031
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.424
article - articoli 0
book - libri 0
conference - conferenze 10.422
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.846
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022578 65 20 39 48 35 42 64 45 37 29 70 84
2022/2023696 64 57 12 97 45 205 54 44 46 12 38 22
2023/2024368 29 59 42 19 17 22 28 37 11 29 31 44
2024/20251.306 19 81 62 91 279 96 42 68 124 114 130 200
2025/20262.452 236 122 137 245 270 105 330 99 227 200 137 344
2026/202772 72 0 0 0 0 0 0 0 0 0 0 0
Totale 6.031